Altered leucocyte trafficking and suppressed tumour necrosis factor a release from peripheral blood monocytes after intra-articular glucocorticoid treatment

Annals of the Rheumatic Diseases

Volumn 57, Issue 12, 1998, Pages 732-737

  Steer, James H ^a   Ma, Dickson T S ^b   Dusci, Leon ^c   Garas, George ^b   Pedersen, Karen E ^a   Joyce, David A ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c Western Australian Centre for Pathology and Medical Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTHROPATHY; ARTICLE; CLINICAL ARTICLE; FEMALE; GRANULOCYTOSIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; LYMPHOCYTOPENIA; MONOCYTE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0032417928     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.12.732     Document Type: Article

References (40)

1. Koehler BE, Urowitz MB, Killinger DW, The systemic effects of intra-articular corticosteroid. J Rheumatol 1974;1:117-25.
2. Armstrong RD, English J, Gibson T, Chakraborty J, Marks V. Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate. Ann Rheum Dis 1981;40:571-1.
3. Swinburn CR, Wakefield JM, Newman SP, Jones PW. Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease. Br J Clin Pharmacol 1988;26:709-13.
4. Karalis K, Mastorakos G, Sano H, Wilder RL, Chrousos GP. Somatostatin may participate in the antiinflammatory actions of glucocorticoids. Endocrinology 1995;136: 4133-8.
5. Star RA, Rajora N, Huang J, Stock RC, Catania A, Lipton JM. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulatmg hormone. Proc Natl Acad Sci USA 1995;92:8016-20.
6. van Woudenberg AD, Metzelaar MJ, van der Kleij AA, de Wied D, Burbach JP, Wiegant VM. Analysis of proopiomelanocortin (POMC) messenger ribonucleic acid and POMC-derived peptides in human peripheral blood mononuclear cells: no evidence for a lymphocyte-derived POMC system. Endocrinology 1993;133:1922-33.
7. Nakai Y, Usui T, Tsukada T, Takahashi H, Fukata J, Fukushima M, et al. Molecular mechanisms of glucocorticoid inhibition of human proopiomelanocortin gene transcription. J Steroid Biochem Mol Biol 1991;40:301-6.
8. Zwilling BS, Lafuse WP, Brown D, Pearl D. Characterization of ACTH mediated suppression of MHC class II expression by murine peritoneal macrophages. J Neuroimmunol 1992;39:133-8.
9. Hagi K, Uno K, Inaba K, Muramatsu S. Augmenting effect of opioid peptides on murine macrophage activation. J Neuroimmunol 1994;50:71-6.
10. Schulte HM, Bamberger CM, Elsen H, Herrmann G, Bamberger AM, Barth J. Systemic interleukin-1α and interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormone in humans. Eur J Clin Invest 1994;24:773-7.
11. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993;119: 1198-208.
12. Steer JH, Vuong Q, Joyce DA. Suppression on human monocyte tumour necrosis factor release by glucocorticoid therapy: relationship to systemic monocytopaenia and cortisol suppression. Br J Clin Pharmacol 1997;43:383-9.
13. Bendrups A, Hilton A, Meager A, Hamilton JA. Reduction of tumor necrosis factor α and interleukin-1β levels in human synovial tissue by interleukin-4 and glucocorticoid. Rheumatol Int 1993;12:217-20.
14. Amano Y, Lee SW, Allison AC. Inhibition by glucocorticoids of the formation of Interleukin-1α, Interleukin-1β, and Interleukin-6: Mediation by decreased mRNA stability. Mol Pharmacol 1993;43:176-82.
15. Standiford TJ, Kunkel SL, Rolfe MW, Evanoff HL, Allen RM, Stricter RM. Regulation of human alveolar macrophage-and blood monocyte-derived interleukin-8 by prostaglandin E2 and dexamethasone. Am J Respir Cell Mol Biol 1992;6;75-81.
16. Hart PH, Whitty GA, Burgess DR, Croatto M, Hamilton JA. Augmentation of glucocorticoid action on human monocytes by interleukin-4. Lymphokine Res 1990;9:147-53.
17. Wenzel I, Roth J, Sorg C. Identification of a novel surface molecule, RM3/1, that contributes to the adhesion of glucocorticoid-induced human monocytes to endothelial cells. Eur J Immunol 1996;26:2758-63.
18. Filep JG, Delalandre A, Payette Y, Foldes-Filep E. Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils. Circulation 1997;96:295-301.
19. Pitzalis C, Pipitone N, Bajocchi G, Hall M, Goulding N, Lee A, et al. Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: an additional mechanism for their anti-inflammatory and immunosuppressive effect. J Immunol 1997;158:5007-16.
20. Sackstein R, Borenstein M. The effects of corticosteroids on lymphocyte recirculation in humans: Analysis of the mechanism of impaired lymphocyte migration to lymph node following methylprednisolone administration. J Invest Med 1995;43:68-77.
21. O'Leary EC, Marder P, Zuckerman SH. Glucocorticoid effects in an endotoxin-induced rat pulmonary inflammation model: differential effects on neutrophil influx, integrin expression, and inflammatory mediators. Am J Respir Cell Mol Biol 1996;15:97-106.
22. Derendorf H, Hochhaus G, Mollmann H, Barth J, Krieg M, Tunn S, et al. Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids. J Clin Pharmacol 1993;33:115-23.
23. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin- 1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
24. Feldmann M, Brennan FM, Elliott M, Katsikis P, Maini RN. TNF-α as a therapeutic target in rheumatoid arthritis. Circ Shock 1994;43:179-84.
25. Haskard DO. Cell adhesion molecules in rheumatoid arthritis. Curr Opin Rheumatol 1995;7:229-34.
26. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries DJ, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
27. Jones A, Regan M, Ledingham J, Pattrick M, Manhire A, Doherty M. Importance of placement of intra-articular steroid injections. BMJ 1993;307:1329-30.
28. Hübl W, Hauptlorenz S, Tlustos L, Jilch R, Fischer M, Bayer PM. Precision and accuracy of monocyte counting: Comparison of two hematology analyzers, the manual differential and flow cytometry. Am J Clin Pathol 1995;103: 167-70.
29. Thompson J, Van Furth R. The effect of glucocorticosteroids on the proliferation and kinetics of promonocytes and monocytes of the bone marrow. J Exp Med 1973;137:10-21.
30. Joyce DA, Steer JH, Beilharz M, Stranger R. A system for assessment of monokine gene expression using human whole blood. Genet. Genetic Analysis: Techniques and Applications 1995;12:31-43.
31. Meager A, Parti S, Leung H, Peil E, Mahon B. Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF). Hybridoma 1987;6:305-11.
32. Joyce DA, Steer JH, Kloda A. Dexamethasone antagonises IL-4 and IL-10-induced release of IL-IRA by monocytes but augments IL-4-, IL-10- and TGF-β-induced suppression of TNF-α release. J Interferon Cytokine Res 1996;16: 513-19.
33. Thompson J, Van Furth R. The effects of glucocorticosteroids on the kinetics of mononuclear phagocytes. J Exp Med 1970;131:429-42.
34. Fauci AS, Dale DC. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest 1974; 53:240-6.
35. Fauci AS, Dale DC. Alternate-day prednisone therapy and human lymphocyte subpopulations. J Clin Invest 1975;55: 22-32.
36. Beelen RHJ, Bos HJ, Kamperdijk EWA, Hoefsmit EGM. Ultrastructure of monocytes and macrophages. In: Zembala M, Asherson GL, eds. Human monocytes. London: Academic Press, 1989:7-25.
37. Meuret G, Hoffmann G. Monocyte kinetic studies in normal and disease states. Br J Haematol 1973;24:275-85.
38. Farsky SP, Sannomiya P, Garcia-Leme J. Secreted glucocorticoids regulate leukocyte-endothelial interactions in inflammation. A direct vital microscopic study. J Leukocyte Biol 1995;57:379-86.
39. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1992; 89:9991-5.
40. Brostjan C, Anrather J, Csizmadia V, Natarajan G, Winkler H. Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun. J Immunol 1997;158: 3836-44.